America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide.
Melanie Sena
Advertisement
Melanie Sena is community editor of Pharmaceutical Technology.
Articles by Melanie Sena
Advertisement
Latest Updated Articles
- 180 Diabetes Medicines in Development in the U.S.
February 18th 2014
Advertisement
Advertisement
Trending on PharmExec
1
Vinay Prasad Out at CBER for Second Time in Under a Year
2
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
3
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
4
Novo Nordisk Signs Deal with Hims & Hers
5